Article Archive: Damien Conover, CFA

Title Collection Author Date
Drug Division Drives Johnson & Johnson US Videos Damien Conover, CFA 04/17/18
A Strong Dividend Yield for Undervalued Novartis US Videos Damien Conover, CFA 04/16/18
Healthcare: Values Among Drug, Biotech, and Supply Chain Firms Quarter-End Insights Damien Conover, CFA 03/30/18
Stock Market Outlook: Stocks Look Slightly Overvalued Today Quarter-End Insights Damien Conover, CFA 03/29/18
Glaxo Undervalued as it Exits Potential Pfizer Deal Stock Analyst Update Damien Conover, CFA 03/26/18
AbbVie's Stock Price Decline Overdone Stock Analyst Update Damien Conover, CFA 03/22/18
Good News for Undervalued Sanofi Stock Analyst Update Damien Conover, CFA 03/12/18
2 Undervalued Innovators in Big Pharma US Videos Damien Conover, CFA 03/07/18
Expect Generic Competition to Weigh on Pfizer Stock Analyst Update Damien Conover, CFA 01/30/18
Robust Drug Sales for Johnson & Johnson Stock Analyst Update Damien Conover, CFA 01/23/18
Sanofi Overpays for Bioverativ Stock Analyst Update Damien Conover, CFA 01/22/18
Earlier Than Expected Good News for Merck Stock Analyst Update Damien Conover, CFA 01/16/18
Healthcare: Pick Carefully as Valuations Head Higher Quarter-End Insights Damien Conover, CFA 12/28/17
2 Undervalued Large-Cap Pharma Names US Videos Damien Conover, CFA 12/20/17
GlaxoSmithKline Dividend Concerns Overblown US Videos Damien Conover, CFA 12/18/17
More Moats, More Profits Advisor Insights Damien Conover, CFA 12/06/17
Astra's Externalized Revenue Is Unsustainable Stock Analyst Update Damien Conover, CFA 11/09/17
Pfizer's New Drugs Offset Generic Competition Stock Analyst Update Damien Conover, CFA 10/31/17
Merck Still a Leader in Immuno-Oncology Stock Analyst Update Damien Conover, CFA 10/30/17
Bayer Posts Slowing Sales Growth in 3Q Stock Analyst Update Damien Conover, CFA 10/26/17
Eli Lilly Posts Solid 3Q as Drugs Drive Top-Line Growth Stock Analyst Update Damien Conover, CFA 10/24/17
Robust Drug Sales Lift Johnson & Johnson's 3rd Quarter Stock Analyst Update Damien Conover, CFA 10/17/17
Johnson & Johnson Looks Overvalued Today US Videos Damien Conover, CFA 10/17/17
Why We Like Eli Lilly Today US Videos Damien Conover, CFA 10/11/17
Pfizer's Divestiture Plan No Big Deal Stock Analyst Update Damien Conover, CFA 10/10/17
Healthcare: Stock Selection Key as Valuations Rise Quarter-End Insights Damien Conover, CFA 09/28/17
Pfizer Looks Undervalued Stock Analyst Update Damien Conover, CFA 08/01/17
Pfizer Remains Underappreciated US Videos Damien Conover, CFA 08/01/17
Lilly Looks Slightly Undervalued Stock Analyst Update Damien Conover, CFA 07/25/17
Japan's Approval of Olumiant Good News for Lilly Stock Analyst Update Damien Conover, CFA 07/03/17
Healthcare: ACA Repeal Efforts Unlikely to Yield Major Legislative Changes Quarter-End Insights Damien Conover, CFA 06/28/17
Our Top 2 Picks Within Immuno-Oncology US Videos Damien Conover, CFA 06/07/17
Undervalued Pfizer Offers Great Dividend Opportunity US Videos Damien Conover, CFA 06/06/17
Solid Pipeline Offsets Competition for AstraZeneca Stock Analyst Update Damien Conover, CFA 05/12/17
Merck Posts Minor Gains in First Quarter Stock Analyst Update Damien Conover, CFA 05/02/17
Patent Losses, Prevnar Weakness Weigh on Pfizer Growth Stock Analyst Update Damien Conover, CFA 05/02/17
AbbVie Posts Solid First Quarter Boosted by Humira Stock Analyst Update Damien Conover, CFA 04/27/17
Valuation Concerns at J&J Stock Analyst Update Damien Conover, CFA 04/18/17
Healthcare: Stock-Picking Increasingly Important as Valuations Rise Quarter-End Insights Damien Conover, CFA 03/31/17
Drug Launches, Diversity Support Bayer's Steady Gains Stock Strategist Damien Conover, CFA 03/29/17
3 Drugmakers With Strong Pricing Power US Videos Damien Conover, CFA 03/15/17
Keytruda Helps Offset Generic Headwinds for Merck Stock Analyst Update Damien Conover, CFA 02/02/17
Pfizer Shares Look Undervalued Stock Analyst Update Damien Conover, CFA 01/31/17
AbbVie Looks Undervalued Stock Strategist Damien Conover, CFA 01/30/17
J&J Shares Fairly Valued After Mixed Fourth Quarter Stock Analyst Update Damien Conover, CFA 01/24/17
Healthcare: What Does a Trump Administration Mean for Healthcare Stocks? Quarter-End Insights Damien Conover, CFA 12/29/16
2 Inexpensive, Innovative Pharma Stocks US Videos Damien Conover, CFA 12/05/16
U.S. Elections Add Uncertainty to Healthcare Stocks Stock Analyst Update Damien Conover, CFA 11/09/16
Pfizer Looks Undervalued Despite Pipeline Setback Stock Analyst Update Damien Conover, CFA 10/31/16
Weak Third Quarter but Eli Lilly Looks Well Positioned Stock Analyst Update Damien Conover, CFA 10/25/16